日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

BRUIN 313 and 314 Trials Open the Door for Noncovalent Bruton Tyrosine Kinase Inhibition as Initial Therapy for Chronic Lymphocytic Leukemia

BRUIN 313 和 314 试验为非共价布鲁顿酪氨酸激酶抑制剂作为慢性淋巴细胞白血病的一线疗法打开了大门

Davids, Matthew S

CD47 blockade-driven necroptosis complements BCL-2 inhibition-driven apoptosis in lymphoid malignancies.

CD47阻断驱动的坏死性凋亡可与BCL-2抑制驱动的淋巴恶性肿瘤细胞凋亡相辅相成。

Chong Stephen J F, Valentin Rebecca, Wang Jing, Zhu Fen, Gokhale Prafulla C, Eschle Benjamin K, Garbicz Filip, Iskandar Kartini, Sewastianik Tomasz, Toh Brienne C Y, Penailillo Johany, Peluso Marisa O, Zhang Jeremy, Hackett Liam, Collins Mary C, Lehmberg Timothy Z, Adam Ammar, Zhang Li, Armet Caroline M, Rausch Matthew, Lee Benjamin H, Holland Pamela M, Palombella Vito J, Paterson Alison M, Kong Li Ren, Ten Hacken Elisa, Guerriero Jennifer L, Herbaux Charles, Wu Catherine J, Chng Wee Joo, Pervaiz Shazib, Niemann Carsten U, Carrasco Ruben D, Davids Matthew S

Targeting β-catenin degradation with GSK3β inhibitors induces cell death in acute lymphoblastic leukemia.

使用 GSK3β 抑制剂靶向 β-catenin 降解可诱导急性淋巴细胞白血病细胞死亡。

Cosgun Kadriye Nehir, Jumaa Huda, Robinson Mark E, Cheng Zhangliang, Oulghazi Salim, Kume Kohei, Fonseca Arce David, Agadzhanian Nikol, Kistner Klaus M, Leveille Etienne, Drivet Elsa, Yu Fang, Qian Zhijian, Song Joo Y, Chan Wing-Chung, Xu Liang, Xiao Gang, Taketo M Mark, Kothari Shalin, Davids Matthew S, Schjerven Hilde, Jellusova Julia, Müschen Markus

Mechanisms of immune escape and extramedullary tropism in leukemia cutis.

白血病皮肤的免疫逃逸和髓外趋向性机制。

Penter Livius, Maurer Katie, Cieri Nicoletta, Lu Wesley S, Lyu Haoxiang, Selig Mischa, Joosten Maria, Ihlow Jana, Li Shuqiang, Livak Kenneth J, Bullinger Lars, Ritz Jerome, Bachireddy Pavan, Davids Matthew S, Garcia Jacqueline S, Soiffer Robert J, Wu Catherine J

First-line treatment for CLL in the era of targeted therapy

靶向治疗时代慢性淋巴细胞白血病的一线治疗

Davids, Matthew S; Stilgenbauer, Stephan; Tam, Constantine S

Safety and efficacy of the combination of copanlisib and nivolumab in patients with Richter's transformation or transformed non-Hodgkin lymphoma: results from a phase I trial

copanlisib 联合 nivolumab 治疗 Richter 转化或转化型非霍奇金淋巴瘤患者的安全性和有效性:一项 I 期试验的结果

Shouse, Geoffrey; Chen, Canping; Muir, Alexandra; Popplewell, Leslie; Siddiqi, Tanya; Zain, Jasmine; Herrera, Alex F; Danilova, Olga; Roleder, Carly; Wang, Lili; Spurgeon, Stephen E F; Kittai, Adam S; Chen, Lu; Xia, Zheng; Davids, Matthew S; Danilov, Alexey V

Central nervous system involvement in CLL: an international retrospective study by ERIC, the European Research Initiative on CLL

慢性淋巴细胞白血病中枢神经系统受累:欧洲慢性淋巴细胞白血病研究倡议(ERIC)的一项国际回顾性研究

Chatzikonstantinou, Thomas; Mikhaleva, Mariia; Brieghel, Christian; Papangelou, Christina; Minga, Eva; Arrais-Rodrigues, Celso; Besikli-Dimou, Sotiria; Cerutti, Amalia; Doubek, Michael; Enggaard, Lisbeth; Espinet, Blanca; Ferrer-Lores, Blanca; Garcia Vela, Jose Antonio; Gentile, Massimo; Vázquez, Eva Gimeno; Gutwein, Odit; Herishanu, Yair; Jablonowska-Babij, Paula; Jaksic, Ozren; Josefsson, Par; Kalicińska, Elzbieta; Kislova, Maria; Lista, Enrico; Kotsianidis, Ioannis; Marquet, Juan; Martino, Enrica Antonia; McAuley, Ciaran; Mela Osorio, Maria José; Moia, Riccardo; Mosquera, Claudia; Nikitin, Eugene; Pavlovsky, Miguel Arturo; Pfister, Verena; Savaş, Emine Merve; Scarfò, Lydia; Sever, Matjaz; Shvidel, Lev; Simkovic, Martin; Stavroyianni, Niki; Talimtzi, Persefoni; Tranidou, Antigoni; Visentin, Andrea; Vrachiolias, Georgios; Wasik-Szczepanek, Ewa; Wróbel, Tomasz; Yağcı, Münci; Cellini, Alessandro; Chatzidimitriou, Anastasia; Gaidano, Gianluca; Anderson, Mary Ann; Davids, Matthew S; Brown, Jennifer R; Niemann, Carsten U; Stamatopoulos, Kostas; Ghia, Paolo; Ahn, Inhye E; Koren-Michowitz, Maya

Efficacy of Pirtobrutinib Monotherapy in Treatment-Naïve Chronic Lymphocytic Leukemia: A Bayesian Network Meta-Analysis of Randomized Controlled Trials

吡托替尼单药治疗初治慢性淋巴细胞白血病的疗效:随机对照试验的贝叶斯网络荟萃分析

Eyre, Toby A; Hess, Lisa M; Masoudi, Ehsan; Jen, Min-Hua; Abhyankar, Sarang; Graham-Clarke, Peita L; Bhandari, Naleen Raj; Maguire, Peter; Winfree, Katherine B; Tracey, Marsha; Taipale, Kaisa-Leena; Davids, Matthew S

Ipilimumab with and without nivolumab in patients with classic Hodgkin lymphoma with progression after PD-1 blockade

伊匹木单抗联合或不联合纳武利尤单抗治疗PD-1阻断后进展的经典霍奇金淋巴瘤患者

Merryman, Reid W; Kline, Justin; Redd, Robert A; Olszewski, Harrison; Welsh, Emma; Pfaff, Kathleen; Lee, Hannah; McDonough, Mikaela; Ahn, Inhye E; Brown, Jennifer R; Crombie, Jennifer L; Davids, Matthew S; Fisher, David C; Jacobsen, Eric D; Jacobson, Caron A; Kim, Austin I; Odejide, Oreofe O; Parry, Erin Michelle; Ryan, Christine E; Shipp, Margaret A; Armand, Philippe; Rodig, Scott; Abramson, Jeremy S; LaCasce, Ann S

Phase II Study of Acalabrutinib, Venetoclax, and Obinutuzumab in a Treatment-Naïve Chronic Lymphocytic Leukemia Population Enriched for High-Risk Disease

在富含高危疾病的初治慢性淋巴细胞白血病患者人群中开展的阿卡替尼、维奈克拉和奥妥珠单抗的II期研究

Davids, Matthew S; Ryan, Christine E; Lampson, Benjamin L; Ren, Yue; Tyekucheva, Svitlana; Fernandes, Stacey M; Crombie, Jennifer L; Kim, Austin I; Weinstock, Matthew; Montegaard, Josie; Walker, Heather A; Greenman, Claire; Patterson, Victoria; Jacobson, Caron A; LaCasce, Ann S; Armand, Philippe; Fisher, David C; Lo, Steve; Olszewski, Adam J; Arnason, Jon E; Ahn, Inhye E; Brown, Jennifer R